Telomeric repeat-binding factor 2: a marker for survival and anti-EGFR efficacy in oral carcinoma.

Benhamou Y, Picco V, Raybaud H, Sudaka A, Chamorey E, Brolih S, Monteverde M, Merlano M, Lo Nigro C, Ambrosetti D, Pages G
Oncotarget. 2016 Jul 12;7(28):44236-44251. doi: 10.18632/oncotarget.10005. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.